Cardiomegaly medical therapy

Jump to navigation Jump to search

Cardiomegaly Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Cardiomegaly from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

MRI

CT

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Cardiomegaly medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cardiomegaly medical therapy

CDC on Cardiomegaly medical therapy

Cardiomegaly medical therapy in the news

Blogs on Cardiomegaly medical therapy

Directions to Hospitals Treating Cardiomegaly medical therapy

Risk calculators and risk factors for Cardiomegaly medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor in Chief: Cafer Zorkun, M.D., Ph.D. [2]

Overview

Diuretics and ACE inhibitors are standard therapy for the chronic treatment of cardiomegaly. Acute therapies include preload and afterload reduction.

Medical Therapy

Acute Pharmacotherapies

Diuretics and nitrates are administered acutely to reduce preload and afterload.

Chronic Pharmacotherapies

A combination of diuretics and angiotensin converting enzyme (ACE) inhibition is currently the standard of care. Digoxin may reduce the frequency of rehospitalization, but does not improve mortality.

References


Template:WH Template:WS